Dev Prasad

Stock Analyst at LUCID CAPITAL MARKETS

(3.14)
# 1,102
Out of 5,182 analysts
6
Total ratings
60%
Success rate
121.88%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Dev Prasad

aTyr Pharma
Sep 15, 2025
Downgrades: Neutral
Price Target: $11$1
Current: $0.79
Upside: +26.44%
Cue Biopharma
Aug 25, 2025
Initiates: Buy
Price Target: $120
Current: $17.93
Upside: +569.27%
Opus Genetics
Jun 17, 2025
Initiates: Buy
Price Target: $5
Current: $5.12
Upside: -2.34%
Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $14.42
Upside: +66.44%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $1.71
Upside: +250.88%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $0.59
Upside: +2,103.02%